E717-0265 Screening compound: N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{4-oxo-5-propyl-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide

E717-0265 Screening compound: N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{4-oxo-5-propyl-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide
E717-0265 Screening compound: N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{4-oxo-5-propyl-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E717-0265
N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{4-oxo-5-propyl-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E717-0265

Molecular Formula

C24H33N5O2 (C24 H33 N5 O2)

Compound Name

N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{4-oxo-5-propyl-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide

IUPAC name

N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{4-oxo-5-propyl-3H4H5H-pyridazino[45-b]indol-3-yl}acetamide

SMILES

CCCn1c(C(N(CC(NCCN(C)C2CCCCC2)=O)N=C2)=O)c2c2c1cccc2

InChI

InChI=1S/C24H33N5O2/c1-3-14-28-21-12-8-7-11-19(21)20-16-26-29(24(31)23(20)28)17-22(30)25-13-15-27(2)18-9-5-4-6-10-18/h7-8,11-12,16,18H,3-6,9-10,13-15,17H2,1-2H3,(H,25,30)

InChI Key

HVUOVCBTAMZXMM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14912136

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

423.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.905

Distribution Coefficient, logD

1.464

Water Solubility, LogSw

-2.99

Polar Surface Area

56.672

Acid Dissociation Constant (pKa)

14.39

Base Dissociation Constant (pKb)

8.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.20

E717-0265 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with E717-0265 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E717-0265?
Check Price and Availability of E717-0265, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E717-0265 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E717-0265
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E717-0265
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E717-0265 available by request